In these mice, treatment with the NOS inhibitor (N-nitro-L-arginine methyl ester) decreased eNOS and NO production, increased vasoconstriction and hypertension, and reduced mouse survival (Quaschning et al., 2003). Here, NOS1 is linked to hypertensive disorder.